Feng Xue, MD

Chief physician
Institute of haematology and Blood Diseaes Hospital, Chinese Academy of Medical Sciences and Pkeing Union Medical College
Tianjin, Tianjin, China (People's Republic)

Dr. Feng Xue is now a Chief physician at Thrombosis& Hemostasis Center，Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences& Peking Union Medical College.
Serves at following academic originations:
1.Deputy leader of thrombosis and Hemostasis Group, Chinese Society of Hematology
2.Deputy Secretary General of Hemophilia Group of China Alliance for Rare Disease
3.Executive director of China Hemophilia Youth Cooperation Group
Representative work:
1. Feng Xue, Huiyuan Li, Xia Wu, et al. Safety and activity of an engineered, liver-tropic adeno-associated virus vector expressing a hyperactive Padua factor IX administered with prophylactic glucocorticoids in patients with haemophilia B: a single-centre, single-arm, phase 1, pilot trial. Lancet Haematol. 2022 Jul;9(7): e504-e513.
2. Feng Xue, Renchi Yang, Lei Zhang, et al. Total Knee Arthroplasty after Gene Therapy for Hemophilia B. N Engl J Med. 2022 Oct 27;387(17):1622-1624.

Presentation(s):

• OC 24.5 - A Phase 1 Study to Evaluate the Pharmacokinetics and Safety of a PEGylated-Recombinant Human Coagulation Factor VIII-Fc Fusion Protein in Patients With Severe Hemophilia A

  Sunday, June 25, 2023
  15:45 – 16:00 ET

• PB1049 - Immune modulatory function of desialylated platelets containing FVIII in FVIII immune responses in hemophilia A mice

  Tuesday, June 27, 2023
  18:30 – 19:30 ET